Formononetin
PreliminaryMechanism of Action
Research Notes
Selective ERβ binding relevant to postmenopausal bone health. Anti-cancer activity against MCF-7, HeLa, and DU145 cell lines. Anti-osteoporotic effects in ovariectomized rat models. Limited human clinical data specific to formononetin.
One small double-blind RCT (n=36) showed reduction in menopausal symptom scores after 12 weeks of standardised extract vs placebo. In vitro bone-protective effects consistently demonstrated. ERβ selectivity may offer safety advantage over non-selective phytoestrogens.
Formononetin undergoes hepatic glucuronidation and enteric metabolism to equol in responsive individuals. Systematic reviews indicate modest benefit for vasomotor symptoms with inconsistent individual responses.
Found In 3 Herbs
3D Molecular Structure
Formononetin
Representative pattern: C₁₅H₁₀O₃
Live Research
This information is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare practitioner before using any herbal product.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This content is for educational purposes only and is not a substitute for professional medical advice.


